LEADER 03861nam 2200661 a 450 001 9911019097803321 005 20200520144314.0 010 $a9780470715420 010 $a0470715421 010 $a9780470715123 010 $a047071512X 035 $a(CKB)1000000000688135 035 $a(EBL)739075 035 $a(OCoLC)775868814 035 $a(SSID)ssj0000668034 035 $a(PQKBManifestationID)11409850 035 $a(PQKBTitleCode)TC0000668034 035 $a(PQKBWorkID)10703229 035 $a(PQKB)11767707 035 $a(MiAaPQ)EBC739075 035 $a(Perlego)2769969 035 $a(EXLCZ)991000000000688135 100 $a19811105d1981 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 10$aHuman muscle fatigue $ephysiological mechanisms 210 $aLondon $cPitman Medical ;$aSummit, N.J. $cDistributed in North America by CIBA Pharmaceutical Co. (Medical Education Administration)$d1981 215 $a1 online resource (326 p.) 225 1 $aCiba Foundation symposium ;$v82 300 $a"Symposium on Human Muscle Fatigue: Physiological Mechanisms, held at the Ciba Foundation, London, 9-11 September 1980"--P. [v]. 300 $aEditors: Ruth Porter (organizer) and Julie Whelan. 311 08$a9780272796184 311 08$a0272796182 320 $aIncludes bibliographical references and indexes. 327 $aHuman muscle fatigue: physiological mechanisms; Contents; Human muscle function and fatigue; Glycolytic and oxidative energy metabolism and contraction characteristics of intact human muscle; Discussion; Muscle fibre recruitment and metabolism in exhaustive dynamic exercise; Discussion; Relevance of muscle fibre type to fatigue in short intense and prolonged exercise in man; Discussion; Effect of metabolic changes on force generation in skeletal muscle during maximal exercise; Discussion; The glucose/fatty acid cycle and physical exhaustion; Discussion 327 $aShortage of chemical fuel as a cause of fatigue: studies by nuclear magnetic resonance and bicycle ergometryDiscussion; Indirect and direct stimulation of fatigued human muscle; Discussion; EMG and fatigue of human voluntary and stimulated contractions; Discussion; Firing pro- perties of single human motor units on maintained maximal voluntary effort; Discussion; Muscle fatigue due to changes beyond the neuromuscular junction; Discussion; Contractile function and fatigue of the respiratory muscles in man\; Discussion; Neural drive and electromechanical altera- tions in the fatiguing diaphragm 327 $aDiscussionThe tremor in fatigue; Discussion; The pathophysiology of inspiratory muscle fatigue; Discussion; Fatigue in human metabolic myopathy; Discussion; General discussion; The perception of fatigue; Electricity or chemistry?; Chairman's summing-up; Index of contributors; Subject index 330 8 $aThe Novartis Foundation Series is a popular collection of the proceedings from Novartis Foundation Symposia, in which groups of leading scientists from a range of topics across biology, chemistry and medicine assembled to present papers and discuss results. The Novartis Foundation, originally known as the Ciba Foundation, is well known to scientists and clinicians around the world. 410 0$aCiba Foundation symposium ;$v82. 606 $aFatigue$xEtiology$vCongresses 606 $aMuscles$xPhysiology$vCongresses 615 0$aFatigue$xEtiology 615 0$aMuscles$xPhysiology 676 $a612.7/4 676 $a612.74 701 $aPorter$b Ruth$064811 701 $aWhelan$b Julie$0322651 712 02$aCiba Foundation. 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9911019097803321 996 $aHuman muscle fatigue$93004876 997 $aUNINA LEADER 02603nam 22005415 450 001 9911034948403321 005 20251020130409.0 010 $a3-032-08179-3 024 7 $a10.1007/978-3-032-08179-7 035 $a(MiAaPQ)EBC32364735 035 $a(Au-PeEL)EBL32364735 035 $a(CKB)41689394000041 035 $a(DE-He213)978-3-032-08179-7 035 $a(EXLCZ)9941689394000041 100 $a20251020d2025 u| 0 101 0 $aeng 135 $aurcnu|||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aEsophageal Disorders $eDiagnosis and Treatment /$fedited by Francisco Schlottmann, Fernando A. M. Herbella, Marco G. Patti 205 $a1st ed. 2025. 210 1$aCham :$cSpringer Nature Switzerland :$cImprint: Springer,$d2025. 215 $a1 online resource (224 pages) 225 1 $aMedicine Series 311 08$a3-032-08178-5 327 $aEsophageal anatomy -- Pathophysiology of Gastroesophageal reflux disease -- Medical therapy for GERD -- Laparoscopic anti-reflux surgery -- Endoscopic Therapies for Gastroesophageal Reflux Disease -- Complications of Gastroesophageal Reflux Disease -- Management of Failed Anti-Reflux Surgery -- Why does fundoplication fail? -- GERD and bariatric surgery -- Achalasia: Diagnostic evaluation -- Treatment modalities for achalasia -- Non-achalasia esophageal motility disorders: Diagnosis and treatment -- Epiphrenic diverticulum -- Eosinophilic Esophagitis. 330 $aThis book will be a state of the art description of the pathophysiology, diagnosis and treatment of benign esophageal disorders. Expert physicians will provide an evidence- and experience-based analysis in each chapter. The expected audience will include primary care physicians, internal medicine doctors, gastroenterologists, pulmonologists, surgeons, as well as medical students. The goal will be to have a comprehensive and detailed book, easy to read, and with clear information. 410 0$aMedicine Series 606 $aSurgery 606 $aGastroenterology 606 $aGeneral Surgery 606 $aGastroenterology 615 0$aSurgery. 615 0$aGastroenterology. 615 14$aGeneral Surgery. 615 24$aGastroenterology. 676 $a617 700 $aSchlottmann$b Francisco$01631693 701 $aHerbella$b Fernando A. M$01631694 701 $aPatti$b Marco G$01631695 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9911034948403321 996 $aEsophageal Disorders$94449221 997 $aUNINA